Journal Home
Search for

Volume 50, Issue 3, Pages 379-395 (September 2007)


View previous. 16 of 27 View next.

Balancing Fistula First With Catheters Last

Eduardo Lacson Jr, MD, MPH1Corresponding Author Informationemail address, J. Michael Lazarus, MD1, Jonathan Himmelfarb, MD2, T. Alp Ikizler, MD3, Raymond M. Hakim, MD1

Received 5 February 2007; accepted 15 June 2007. published online 07 August 2007.

The success of Fistula First nationwide has been accompanied by an unplanned increase in hemodialysis catheters. Complications related to prolonged hemodialysis catheter use include increased morbidity, mortality, and cost. We hypothesize that the national focus on increasing fistulas may have inadvertently diverted attention away from initiatives to decrease dependence on hemodialysis catheters. Based on a synthesis of guidelines, reviews, published evidence, and the authors’ opinions, we propose that the national vascular access initiative be revised to have a dual goal of Fistula First and “Catheters Last.” These goals are not mutually exclusive, but rather complementary. We recommend a systematic refocus on interventions that not only increase fistulas, but help avoid extended catheter use. Clearly, the ideal practice for hemodialysis vascular access remains early placement of fistulas with enough maturation time such that they can be used for initiating long-term hemodialysis therapy when the need arises. To effect this change, a reimbursement policy covering the costs associated with permanent access placement before the need for dialysis is essential. Individualized patient management strategies may consider such innovative approaches as initiating patients on peritoneal dialysis therapy or using nonautogenous grafts as bridge accesses in lieu of catheters. For patients who are dialyzing using catheters, immediate active planning for permanent access placement and removal of the catheter is necessary. In the same vein as Fistula First, the renal community should once again be galvanized in working together toward controlling the catheter epidemic in our dialysis population.

1 Fresenius Medical Care, North America, Waltham, MA

2 Maine Medical Center, Portland, ME

3 Vanderbilt University Medical Center, Nashville, TN.

Corresponding Author InformationAddress correspondence to Eduardo Lacson Jr, MD, MPH, Vice President, Clinical Science, Epidemiology, and Research, Fresenius Medical Care, North America, 920 Winter St, Waltham, MA 02451-1457.

 Originally published online as doi: 10.1053/j.ajkd.2007.06.006 on August 6, 2007.

PII: S0272-6386(07)00926-2

doi:10.1053/j.ajkd.2007.06.006


View previous. 16 of 27 View next.